You searched for 0 | 第 50 页，共 144 页

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software Blog Post

AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies RADNOR, PA – 2024 年 6 月 17 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug…

Using Real World Data in Clinical Trial Submissions Blog Post

We explore challenges & best practice recommendations to help you implement submission standards when using Real World Data in clinical trials.

CoAuthor™ Demo Blog Post

Learn more about CoAuthor™

Certara Recognized as a Top Biopharma Workplace for 2024 Blog Post

RADNOR, PA – 2024 年 6 月 12 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, today announced that the Company was certified as a Great Place to…

How QSP Brings Insights and Accelerates Bispecific Antibody Drug Development [China Webinar] Blog Post

超过 50 种结构形式多样的双特异性抗体正在肿瘤临床开发中，针对多种免疫和肿瘤靶点。Bispecific have demonstrated the potential…

Adaptive Trial Design for Phase 1 Dose-Finding Studies Blog Post

Greater flexibility, efficiency and quicker dissemination of research findings to patient communities that stand to benefit are all potential advantages of adaptive trial design as compared to more conventional methods…

Thank you – BaseCase Demo Apps Page

BaseCase Interactive Demo Apps Learn more about BaseCase Login to BaseCaseSchedule a demo Experience BaseCase with the Interactive Demo Apps Explore our full collection of demo apps to see how...

BaseCase Demo Apps Page

BaseCase Explore our Interactive Demo Apps Learn more about BaseCase Login to BaseCaseSchedule a live demo Transform your value communication with BaseCase BaseCase makes it easy to create interactive presentations...